Skip to content
MarketScale
‹ Back to IndustriesSoftware & Technology

Oncology and Technology: Improving the Lives of Cancer Patients Through Better Outcomes

Cancer treatment and care can heavily benefit from data-driven improvements focusing on quality of life. Aaron Galaznik, Chief Scientific Officer of Carevive, shared insights on how data and analytics enhance oncology practices by improving patient experience and care delivery.

This story was produced through MarketScale. See how Software & Technology teams put it to work with Executive Thought Leadership.

By James Kent · AnalyticsCancerCareviveData
Share
Oncology and Technology: Improving the Lives of Cancer Patients Through Better Outcomes

Key takeaways

01

Data and analytics can significantly improve oncology care delivery and patient outcomes.

02

Automating data gathering in clinical care can make the process more efficient and actionable.

03

Building out registries and expanding analytics can help healthcare companies better utilize data for research and decision-making.

Cancer treatment and care can be complex and often focuses on quality of life. The ecosystem of care delivery touches many aspects, and most of these can see improvement with the power of data. Discussing the topic, Oncology and Technology host James Kent spoke with Aaron Galaznik, MD, Chief Scientific Officer of Carevive.

Galaznik was on a path to becoming a physician when he learned about other healthcare avenues. “The year after college, I was interning as a hospital administrator with this career in mind. I was interested in measuring care and what measures are used,” he said.

Those experiences led Galaznik to be very data-centric. He graduated from medical school and earned an MBA in healthcare management. Later, he spent time in life sciences with Pfizer before becoming more excited about using data and analytics and applying them to healthcare problems.

In his data roles, Galaznik began to study oncology. “Oncology lags from research to practice with an emphasis on quality of life,” he explained.

At this time, he was building out a real data practice for a company that did clinical trial data capture to make them more efficient and the data actionable and usable. That brought him to Carevive, where he works on its platform for oncology practices, which tracks the patient experience and improves care delivery. “We make it easy to use. It automates data gathering to apply it to day-to-day clinical care.”

Galaznik also expressed his top priorities at Carevive. “We gather lots of rich data. Number one is building out the registry for research purposes. Expanding analytics offerings to help companies understand how to use the data, and diversifying to other data.”

About the author

JK
James KentPodcast Host and Content Creator

Dependable leader and Podcaster with more than 12 years of results-oriented brand marketing and agency management experience including a broad range of competencies: Adaptive communication and presentation skills. A manager who coaches, mentors and leads. Ability to successfully work cross-functionally within every level of an organization. Strong focus on innovative marketing solutions. Outstanding client relationship building and strategic account management support. Thrives in fast-paced environments with multiple deliverables. Podcast host and content creator.

Software & Technology: are you visible to AI?

Before they reach out, Software & Technology buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Software & Technology expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's Software & Technology expertise into the articles, video, and social content B2B marketing buyers in your industry are searching for. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Software & Technology Insights

The 2026 Forbes AI 50 reveals a $305.6 billion private market consolidating fast around a handful of giants

The 2026 Forbes AI 50 reveals a $305.6 billion private market consolidating fast around a handful of giants

The Forbes AI 50 list in 2026 highlights a $305.6 billion private AI market that is rapidly being dominated by a few major companies. OpenAI and Anthropic together account for 80% of the total funding among the listed companies, indicating a significant capital concentration. However, the emergence of 20 newcomers suggests that there remains room for innovation and growth, especially in sectors like fintech.

  • 01OpenAI and Anthropic account for 80% of the total funding on the Forbes AI 50.
  • 02The total market size for the AI industry is valued at $305.6 billion.
  • 03There are 20 new companies on the Forbes AI 50 list, indicating continued innovation.

Aug 1, 2026

Employee distrust and skills gaps are the real barriers slowing enterprise AI scale in 2026

Employee distrust and skills gaps are the real barriers slowing enterprise AI scale in 2026

The main challenges to scaling enterprise AI in 2026 are employee distrust and a widening skills gap rather than technological readiness. Companies like Microsoft, Salesforce, and Google have the platforms ready, but workforce trust and skills remain barriers.

  • 01Employee distrust is a significant barrier to scaling enterprise AI.
  • 02A widening AI skills gap is hindering technological progress within companies.
  • 03Platforms from major companies like Microsoft, Salesforce, and Google are technically ready for AI scaling.

Aug 1, 2026

Anthropic and Blackstone launch $1.5B AI implementation firm Ode, betting enterprise deployment beats model-building

Anthropic and Blackstone launch $1.5B AI implementation firm Ode, betting enterprise deployment beats model-building

Ode, a $1.5 billion joint venture involving Anthropic, Blackstone, and Goldman Sachs, aims to integrate AI into enterprise operations. The venture employs 100 engineers to focus on the deployment of AI technology across various business sectors. The firm's strategy is to prioritize AI implementation over developing new AI models.

  • 01Ode is a $1.5 billion joint venture promoting AI integration in enterprises.
  • 02The venture employs 100 engineers for AI deployment.
  • 03Ode focuses on implementation rather than creating new AI models.

Jul 31, 2026

Explore More Software & Technology Insights

Read more expert perspectives from across Software & Technology.

Browse Software & Technology Hub

About the Experts

JK
James Kent

Host, Oncology and Technology

Dependable leader and Podcaster with more than 12 years of results-oriented brand marketing and agency management experience including a broad range of competencies: Adaptive communication and presentation skills. A manager who coaches, mentors and leads. Ability to successfully work cross-functionally within every level of an organization. Strong focus on innovative marketing solutions. Outstanding client relationship building and strategic account management support. Thrives in fast-paced environments with multiple deliverables. Podcast host and content creator.

AG
Aaron Galaznik

Chief Scientific Officer

Carevive

Aaron Galaznik is the Chief Scientific Officer at Carevive. He has a background in medicine and healthcare management, and has experience in life sciences and data roles, including a tenure at Pfizer. He focuses on using data and analytics to improve oncology care delivery and patient experience.

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Software & Technology and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512